Ozkan, A. Et Al. 2020. Posttherapeutic Critical Organ Dosimetry of Extensive Lu-177-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results. CLINICAL NUCLEAR MEDICINE , vol.45 , 288-291.

Ozkan, A., Ucar, B., Seymen, H., Yarar, Y., Falay, F. O., & Demirkol, M. O., (2020). Posttherapeutic Critical Organ Dosimetry of Extensive Lu-177-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results. CLINICAL NUCLEAR MEDICINE , vol.45, 288-291.

Ozkan, Ahu Et Al. "Posttherapeutic Critical Organ Dosimetry of Extensive Lu-177-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results," CLINICAL NUCLEAR MEDICINE , vol.45, 288-291, 2020

Ozkan, Ahu Et Al. "Posttherapeutic Critical Organ Dosimetry of Extensive Lu-177-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results." CLINICAL NUCLEAR MEDICINE , vol.45, pp.288-291, 2020

Ozkan, A. Et Al. (2020) . "Posttherapeutic Critical Organ Dosimetry of Extensive Lu-177-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results." CLINICAL NUCLEAR MEDICINE , vol.45, pp.288-291.

@article{article, author={Ahu Ozkan Et Al. }, title={Posttherapeutic Critical Organ Dosimetry of Extensive Lu-177-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results}, journal={CLINICAL NUCLEAR MEDICINE}, year=2020, pages={288-291} }